etx-diabetes-ch49-fig2

Figure 2. The prandial glycemic effects of RYGB are exaggerated in patients with late-complication of hypoglycemia. RYGB enhances prandial glycemic excursion and increases insulin secretion rate (ISR) along with plasma GLP-1 concentrations. Patients with documented hypoglycemia after RYGB have greater insulin and GLP-1 secretin compared to those without. Following RYGB, glucagon response to meal ingestion is enhanced but there is no further increase in response to hypoglycemia. Adapted with permission from Salehi, JCEM, 2014.